Cargando…
COMPARISON OF INTRAVITREAL INJECTION OF RANIBIZUMAB VERSUS LASER THERAPY FOR ZONE II TREATMENT-REQUIRING RETINOPATHY OF PREMATURITY
PURPOSE: To compare the efficacy of intravitreal injection of ranibizumab (IVR) monotherapy and laser therapy for treatment-requiring retinopathy of prematurity (ROP) in Zone II. METHODS: A prospective, randomized, controlled single-center trial was applied from January 2014 to December 2014; infant...
Autores principales: | Zhang, Guoming, Yang, Mingmin, Zeng, Jian, Vakros, Georgios, Su, Kangjin, Chen, Miaohong, Li, Huilin, Tian, Ruyin, Li, Na, Tang, Song, He, Honghui, Tan, Wenjing, Song, Xiangmei, Zhuang, Runsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Retina
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5388026/ https://www.ncbi.nlm.nih.gov/pubmed/27529839 http://dx.doi.org/10.1097/IAE.0000000000001241 |
Ejemplares similares
-
Intravitreal Ranibizumab for Aggressive Posterior Retinopathy of Prematurity
por: Li, Xiu-Juan, et al.
Publicado: (2016) -
Comparison of OCT angiography in children with a history of intravitreal injection of ranibizumab versus laser photocoagulation for retinopathy of prematurity
por: Zhao, Jinfeng, et al.
Publicado: (2020) -
Study of the Biological Developmental Characteristics of the Eye in Children After Laser Surgery for the Treatment of Retinopathy of Prematurity
por: Zeng, Xianlu, et al.
Publicado: (2022) -
Intravitreal ranibizumab monotherapy to treat retinopathy of prematurity zone II, stage 3 with plus disease
por: Menke, Marcel N, et al.
Publicado: (2015) -
Combined intravitreal ranibizumab and zone I sparing laser ablation in infants with posterior zone I retinopathy of prematurity
por: Parchand, Swapnil M, et al.
Publicado: (2021)